Increase of intracellular Ca2+ concentration is essential for glucose-induced insulin secretion. Type 2 ryanodine receptor (RyR2) is a Ca2+ release channel that mobilizes Ca2+ from the endoplasmic reticulum to the cytosol. Unlike RyR2 mRNA expressed in heart, RyR2 mRNA expressed in pancreatic β cells lacks exon 75, probably due to a unique splice donor site “gg” of intron 75 in RyR2 gene. We previously reported that the alteration of splicing in RYR2 caused impaired insulin biosynthesis in human 1.1B4 β cells. Here, to further investigate the significance of RyR2 alternative splicing in vivo, especially glucose-induced insulin secretion, we generated the homozygous genome-modified mice, named RyR2Ex75KI/Ex75KI, in which exon 75-containing RyR2 is expressed systemically including pancreatic β cells by using CRISPR/Cas9 system. Immunohistochemical analysis of pancreas from 15-week-old RyR2Ex75KI/Ex75KI and control wild-type (WT) mice revealed that the size of islets in RyR2Ex75KI/Ex75KI mice was almost the same as that in WT mice, while the insulin-positive area per islet was significantly decreased (0.44-fold, P=0.005). Isolated islets from 9- to 12-week-old mice of each genotype were stimulated by low (2.8 mmol/L) or high (20 mmol/L) glucose for 1 h and secreted insulin was measured by ELISA. Insulin secretion after low glucose treatment from RyR2Ex75KI/Ex75KI islets was significantly higher than that from WT islets (5.27-fold, P=0.019), and insulin secretion after high glucose stimulation was not increased (0.77-fold relative to low glucose stimulation). Intraperitoneal glucose tolerance test (2 g/kg) for 120 min on 14- to 19-week-old mice revealed that blood glucose levels did not differ between genotypes and serum insulin levels at 60-120 min after the glucose challenge were slightly higher in RyR2Ex75KI/Ex75KI mice. Taken together, our results suggest that the WT splice variant of RyR2 would have a crucial role in glucose-induced insulin secretion in vivo.

Disclosure

M. Makino: None. T. Uchiyama: None. Y. Oshima: None. T. Daikoku: None. Y. Yamamoto: None. H. Okamoto: None. S. Nakamura: None. S. Takasawa: None.

Funding

JSPS KAKENHI Grant Number JP21K15375

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.